| Epidemiology from Literature | | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography | | 1.9 - Pollen Allergy | 2014 | Czech Republic | IgE | 826 | 7.400 | 20140606, Panzner P
| | 5.2.1 - Source Exposed (Symptoms, SPT) | 2014 | Spain | IgE | 103 | 18.200 | 20141003, Beitia JM
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2014 | Germany | IgE | 101 | 8.910 | 20140306, Darsow U
| | 1.11 - Esophagitis, Diagnosed | 2014 | Spain | IgE | 67 | 6.000 | 20140625, Armentia A
| | 1.1 - Asymptomatic | 2014 | Spain | IgE | 50 | 0.000 | 20140625, Armentia A
| | 1.9 - Pollen Allergy | 2014 | Spain | IgE | 50 | 14.000 | 20140625, Armentia A
| | 5.2.5 - Source Exposed, Children (Symptoms, IgE) | 2014 | Spain | IgE | 45 | 31.110 | 20140618, Cases B
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2014 | Sweden | IgE | 37 | 11.000 | 20140127, Konradsen JR
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2014 | Sweden | IgE | 28 | 7.000 | 20140127, Konradsen JR
| | 5.2.1 - Source Exposed (Symptoms, SPT) | 2013 | Spain | IgE | 175 | 6.800 | 20130807, Letran A
| | 1.5 - Atopic Dermatitis, Diagnosed | 2013 | Germany | IgE | 140 | 4.290 | 20130111, Ott H
| | 1.11 - Esophagitis, Diagnosed | 2013 | Netherlands | IgE | 76 | 7.800 | 20131020, van Rhijn BD
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2013 | Austria | IgE | 49 | 16.300 | 20131014, Bokanovic D
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2013 | Austria | IgE | 49 | 16.000 | 20131014, Bokanovic D
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2013 | Austria | IgE | 49 | 14.000 | 20131014, Bokanovic D
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2013 | Netherlands | IgE | 41 | 16.280 | 20130429, Aalberse JA
| | 1.11 - Esophagitis, Diagnosed | 2013 | Switzerland | IgE | 35 | 31.430 | 20130605, Simon D
| | 4.1.8 - Heterologous Source Sensitized (SPT, IgE) | 2013 | Netherlands | IgE | 22 | 13.640 | 20130429, Aalberse JA
| | 4.1.3 - Heterologous Source Sensitized (SPT) | 2013 | Italy | IgE | 18 | 100.000 | 20131031, Bonura A
| | 6.2 - General Population (Adults) | 2012 | Sweden | IgE | 371 | 0.540 | 20120528, Patelis A
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Belgium | IgE | 99 | 16.160 | 20110223, De Knop KJ
| | 1.2.1 - Asthma, Diagnosed (Adults) | 2012 | Sweden | IgE | 96 | 2.080 | 20120528, Patelis A
| | 5.2.5 - Source Exposed, Children (Symptoms, IgE) | 2012 | Czech Republic | IgE | 82 | 78.100 | 20120424, Sekerkova A
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2012 | Spain | IgE | 68 | 14.700 | 20120726, Pedrosa M
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2012 | Spain | IgE | 55 | 12.700 | 20120726, Pedrosa M
| | 5.2.4 - Source Exposed, Adults (Symptoms, IgE) | 2012 | Czech Republic | IgE | 48 | 12.500 | 20120424, Sekerkova A
| | 10.1 - Normal Control | 2012 | Belgium | IgE | 27 | 0.000 | 20110223, De Knop KJ
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2011 | Italy | IgE | 43 | 93.020 | 20110214, Villalta D
| | 5.2.1 - Source Exposed (Symptoms, SPT) | 2011 | Spain | IgE | 43 | 25.600 | 20110713, Cabrera-Freitag P
| | 1.10 - Any allergy symptom, Diagnosed | 2010 | Italy | IgE | 16408 | 3.360 | 20100301, Scala E
| | 1.10 - Any allergy symptom, Diagnosed | 2010 | Belgium | IgE | 86 | 9.302 | 20101214, Gadisseur R
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Belgium | IgE | 37 | 13.510 | 20090826, Ebo DG
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Austria | IgE | 32 | 22.000 | 20090211, Constantin C
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Austria | IgE | 22 | 36.000 | 20090211, Constantin C
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2009 | Belgium | IgE | 22 | 4.550 | 20091121, Ebo DG
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Italy | IgE | 21 | 0.000 | 20090808, Krause S
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2009 | Belgium | IgE | 20 | 70.000 | 20091121, Ebo DG
| | 1.5 - Atopic Dermatitis, Diagnosed | 2009 | Germany | IgE | 20 | 10.000 | 20091005, Ott H
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2009 | Austria | IgE | 17 | 35.000 | 20090211, Constantin C
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Spain | IgE | 17 | 88.230 | 20091215, Tordesillas L
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2009 | Italy | IgE | 7 | 100.000 | 20091030, Quercia O
| | 4.1.2 - Heterologous Source Sensitized (Symptoms, SPT) | 2008 | Spain | IgE | 50 | 0.000 | 20080413, Luengo O
| | 4.1.8 - Heterologous Source Sensitized (SPT, IgE) | 2005 | Italy | IgE | 220 | 60.800 | | | 3.2.1 - Source Sensitized (IgE) | 2005 | Finland | IgE | 57 | 10.000 | | | 3.2.1 - Source Sensitized (IgE) | 2005 | Russian Federation | IgE | 12 | 0.000 | | | 3.1.1 - Source Sensitized (SPT) | 2003 | Italy | IgE | 749 | 15.200 | | | 3.2.1 - Source Sensitized (IgE) | 2003 | Austria | IgE | 25 | 24.000 | | | 3.2.1 - Source Sensitized (IgE) | 2003 | Zimbabwe | IgE | 25 | 7.000 | | | 3.1.4 - Source Sensitized (SPT, IgE) | 2001 | Italy | IgE | 77 | 35.100 | | | 5.3.1 - Source Exposed (Symptoms, IgE) | 1994 | Austria | IgE | 30 | 20.000 | |
|
Loading...
Phl p 12
